Does antithymocyte globulin have a place in reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation?
2012 ◽
Vol 2012
(1)
◽
pp. 246-250
◽
Keyword(s):
Abstract A 63-year-old male patient without siblings is treated for acute myeloid leukemia with poor prognostic cytogenetics. Despite achieving a first complete remission, he relapsed within the first year of diagnosis. He then achieved a second complete remission. A search for an HLA-identical unrelated donor identified a 10/10 possible match. The patient has several comorbidities (hematopoietic stem cell comorbidity index = 3) and it is recommended that he undergo a reduced-intensity conditioning regimen for allogeneic peripheral blood stem cell transplantation. The patient is well-read on allogeneic stem cell transplantation and asks you the merits of antithymocyte globulin that you propose to include in the conditioning regimen.
2010 ◽
Vol 16
(2)
◽
pp. S231
2019 ◽
Vol 25
(10)
◽
pp. 1993-2001
◽
2006 ◽
Vol 38
(12)
◽
pp. 783-787
◽
2020 ◽
2016 ◽
Vol 22
(5)
◽
pp. 884-888
◽
2012 ◽
Vol 40
(11)
◽
pp. 892-898
◽
2007 ◽
Vol 13
(2)
◽
pp. 78-79